Incentive plans for drug makers who highly national contributed.

"To save the NHI finance the government should reflect the nation's contribution of the pharmaceutical company in the diverse drug pricing determination policies including the adoption of a positive NHI drug pricing system" said by Dr. Lee Hee-gyeong of Korea Institute for Health and Social Affairs in the Spring conference of the Pharmaceutical Society of Korea held at Bexco in Busan on April 1...